Sign in / Join Now
ETFs & Funds
, korlym sales seemed pretty weak taking in consideration it is a orphan drug indication. Neutral.
Add a reply...
Latest StockTalks »
people get CORT breaking news and analysis by email alert.
Get email alerts on CORT »
Corcept Therapeutics Incorporated
Get latest price
From other sites
Zacks.com featured highlights: Arcos Dorados Holdings, Corcept Therapeutics, Exelixis, Hecla Mining and Lexington Realty Trust
at Zacks.com (Jun 29, 2016)
Corcept Therapeutics (CORT) Jumps: Stock Moves Up 9.6%
at Zacks.com (Apr 1, 2016)
The Zacks Analyst Blog Highlights: Corcept Therapeutics, Epizyme, Geron and Synthetic Biologics
at Zacks.com (Mar 29, 2016)
Can The Uptrend Continue for Corcept Therapeutics (CORT)?
at Zacks.com (Mar 23, 2016)
The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Corcept Therapeutics, Sucampo Pharmaceuticals and Actelion
at Zacks.com (Mar 18, 2016)